Exchange Announcement • 11 Oct 2026 18:30
Voluntary Announcement - Marketing Authorization Application Of Aumolertinib In The Eu Resubmitted And Validated By The Ema
Exchange Announcement • 27 Sep 2026 18:08
Voluntary Announcement - Update On The Marketing Authorization Status Of Aumolertinib In The Eu
Exchange Announcement • 24 Sep 2026 19:30
Voluntary Announcement - Biologics License Application Of Risvutatug Rezetecan For Injection (Hs-20093) For Osteosarcoma Accepted By The Nmpa
Exchange Announcement • 23 Sep 2026 17:06
Notification Letter To Non-Registered Holders And Request Form
Exchange Announcement • 23 Sep 2026 17:02